Journal Issue

Prostate Cancer: A Review of Current Prostate Cancer Markers and a Novel Model of Organization

This issue of Grand Rounds in Urology provides a thorough review of available biomarkers and genomic tests for diagnosing clinically significant prostate cancer. It also discusses the challenges, implementation, and costs associated with these tests, and offers an algorithm incorporating the latest data for clinical use. GRU14-1_Web Keywords prostate carcinoma, biomarkers, PSA screening, antiandrogens, biopsy, aggressive prostate cancer Faculty Medical Editor: E. David Crawford, MD Professor of Surgery, Urology, and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of Colorado, Denver Aurora, Colorado Faculty: Paul Arangua Research Assistant University of Colorado, Denver Aurora, CO   Salvatore P....

Read More

Current and Future Approaches to Androgen Deprivation Therapies: Focus of Antiandrogens

This issue of Grand Rounds in Urology reviews the current and future use of ADT in treating advanced prostate cancer, but with cost of healthcare an ever growing factor in treatment decisions, it will also examine the potential use of older antiandrogen therapies in treating patients with advanced PCa. Presentation GRU13.2_final   Keywords prostate carcinoma, antiandrogens Faculty Medical Editor: E. David Crawford, MD Professor of Surgery, Urology, and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of Colorado, Denver Aurora, Colorado   Faculty: Gerald L. Andriole, Jr., MD Robert Killian Royce Distinguished Professor...

Read More

Prevention, Screening, and Genomic Markers Panel Discussion

Drs. M. Scott Lucia, E. David Crawford, Gerald L. Andriole, Stacy Loeb, and Omer Kucuk presented at the 26th International Prostate Cancer Update on Thursday, January 21, 2016 on “Prevention, Screening, and Genomic Markers Panel Discussion.”   Keywords: prostate cancer, genomic markers, PHI, PSA How to cite: Lucia, M. Scott, et al. “Prevention, Screening, and Genomic Markers Discussion.” Grand Rounds in Urology. January 21, 2016. Dec 2017. https://grandroundsinurology.com/prostate-cancer-m-scott-lucia-et-al-prevention-screening-genomic-markers-discussion/. Transcript Prevention, Screening, and Genomic Markers Discussion DR. LUCIA: We’ve got questions that have come up. So we’ll start with you Stacy. You have published that you feel that PHI is superior to PCA3....

Read More

Highlights from the 24th International Prostate Cancer Update

Presentation Overview and Statement of Need Patterns of care in prostate cancer (PCa) have changed tremendously in the past 20 years, altering the way patients with this tumor present and how they are evaluated before and after diagnosis. With the use of new and combined treatments, the frequency and variety of complications have differed from those previously reported. Advances have been made in PCa imaging, biopsy methodology, in understanding causative factors and disease, in treatment-related quality of life, and in predicting the behavior of individual tumors using risk strata. Despite these advances, no consensus has emerged regarding the optimal...

Read More

Join the GRU Community

- Why Join? -